HIND Dividende : Vyome Holdings Inc Analyse du rendement



Dividendes

HIND Dividendes

Vyome Holdings Inc

$2.1

-4.54%

$-0.1

À la fermeture : May 07, 16:00:00 GMT-4

$2.08

-0.53%

$-0.01

Post-Marché: May 07, 20:00:00 GMT-4

Aperçu Prévision Gagner Dividendes Comptes financiers

Statistiques clés

Clôture préc.

$2.2

Prix d'ouverture

$2.19

Plage de la journée

$2.08 - $2.21

Plage de 52 semaines

$1.75 - $46.6

Volume

6.1K

Volume moyen

597.7K

Rendement en dividend

BPA (TTM)

63.63

Capitalisation boursière

$14.6M

Qu’est-ce que HIND ?

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.